Brazilian Registry for Clinical Presentation of Individuals With COVID-19 (SARS-Brazil)
NCT ID: NCT04479488
Last Updated: 2023-03-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1587 participants
OBSERVATIONAL
2020-07-27
2022-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main goal is to describe mortality incidence, demographic characteristics, coexisting conditions, treatments, outcomes among SARS-CoV2 infected patients.
A secondary goal is to identify biological factors (OMICS - genomic, proteomic and metabolomics characterization) associated with severity conditions for these patients.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Incidence, Associated Factors, and Burden of Post COVID-19 Condition in Brazil
NCT05822193
CORE Study COVID-19
NCT04531202
Study of Methicillin-resistant Staphylococcus Aureus (MRSA) Isolated From Infected Patients in Brazil
NCT01359358
The South Proxa-Rescue AndroCoV Trial Against COVID-19
NCT05126628
Prevention of COVID-19 Complications in High-risk Subjects Infected by SARS-CoV-2 and Eligible for Treatment Under a Cohort ATU ('Autorisation Temporaire d'Utilisation') OR or Authorisation for Early Access (AAP). A Prospectvie Cohort.
NCT04885452
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hospitalized patients
Patient who are suspected or confirmed SARS-CoV2 infection need hospitalization.
Hospital admission
Usual care.
Non-hospitalized patients
Patient who are suspected or confirmed SARS-CoV2 infection non-hospitalized.
Non-hospitalization procedures
Usual care.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hospital admission
Usual care.
Non-hospitalization procedures
Usual care.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Confirmed or suspected SARS-CoV2 infection
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ministry of Health, Brazil
OTHER_GOV
Hospital Israelita Albert Einstein
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Otávio Berwanger, PhD
Role: STUDY_DIRECTOR
Hospital Israelita Albert Einstein
Henrique A Fonseca, PhD
Role: PRINCIPAL_INVESTIGATOR
Hospital Israelita Albert Einstein
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital de Emergencia Dr. Daniel Houly
Arapiraca, Alagoas, Brazil
Alencar Serviços Médicos Ltda
Barbalha, Ceará, Brazil
Hospital Estadual Jayme dos Santos Neves
Serra, Espírito Santo, Brazil
Hospital Santa Rita de Cássia
Vitória, Espírito Santo, Brazil
Universidade Federal da Bahia
Vitória da Conquista, Estado de Bahia, Brazil
Fundação Educacional Lucas Machado
Belo Horizonte, Minas Gerais, Brazil
Fundação Hopitalar São Francisco de Assis
Belo Horizonte, Minas Gerais, Brazil
Hospital Santa Lucia
Poços de Caldas, Minas Gerais, Brazil
Hospital Giselda Trigueiro
Natal, Rio Grande do Norte, Brazil
Hospital São Vicente de Paulo
Passo Fundo, Rio Grande do Sul, Brazil
Santa Casa de Votuporanga
Votuporanga, São Paulo, Brazil
Hospital Municipal Vila Santa Catarina
São Paulo, , Brazil
Hospital São Camilo - Ipiranga
São Paulo, , Brazil
Hospital São Camilo - Pompéia
São Paulo, , Brazil
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Fonseca HAR, Pereira AJ, Nawa RK, Sant'Anna VAR, Almeida TF, Guimaraes HP, Tognon AP, Marques LM, Silva LSCD, Bittencourt RS, Gomes CP, Martins PA, Oliveira AL, Milan EP, Dall'Orto FTC, Hoffman Filho CR, Almeida G, Hohmann FB, Moia DDF, Piano LPA, Machado FP, Soares RVP, Damiani LP, Assis SRL, Amaro Junior E, Rizzo LV, Berwanger O. Mortality, hospitalizations, and persistence of symptoms in the outpatient setting of the first COVID-19 wave in Brazil: results of SARS-Brazil cohort study. Einstein (Sao Paulo). 2024 Aug 9;22:eAO0652. doi: 10.31744/einstein_journal/2024AO0652. eCollection 2024.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
30047620.3.0000.0071
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.